Rockefeller Capital Management L.P. Amicus Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$9.89 - $12.7 $6,725 - $8,636	-680 Reduced 69.39%	300 $3,000
Q3 2022 Nov 02, 2022	SELL	$9.82 - $12.75 $1,433 - $1,861	-146 Reduced 12.97%	980 $10,000
Q2 2022 Aug 12, 2022	SELL	$6.23 - $11.12 $1,669 - $2,980	-268 Reduced 19.23%	1,126 $12,000
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $5,956 - $9,422	-755 Reduced 35.13%	1,394 $13,000
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $9,859 - $12,489	1,004 Added 87.69%	2,149 $24,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $603 - $816	-69 Reduced 5.68%	1,145 $10,000
Q2 2021 Aug 10, 2021	BUY	$8.71 - $10.72 $9,136 - $11,245	1,049 Added 635.76%	1,214 $11,000
Q1 2021 May 11, 2021	SELL	$9.2 - $23.86 $8,123 - $21,068	-883 Reduced 84.26%	165 $1,000
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $123,802 - $228,763	-9,191 Reduced 89.76%	1,048 $24,000
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $11,059 - $13,633	858 Added 9.15%	10,239 $143,000
Q2 2020 Aug 12, 2020	SELL	$8.86 - $15.69 $292 - $517	-33 Reduced 0.35%	9,381 $142,000
Q1 2020 May 12, 2020	SELL	$6.63 - $11.16 $20,460 - $34,439	-3,086 Reduced 24.69%	9,414 $87,000
Q4 2019 Feb 07, 2020	SELL	$7.48 - $10.75 $15,334 - $22,037	-2,050 Reduced 14.09%	12,500 $122,000
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $23,995 - $39,644	2,992 Added 25.89%	14,550 $117,000
Q2 2019 Aug 09, 2019	BUY	$10.96 - $14.4 $125,985 - $165,528	11,495 Added 18246.03%	11,558 $144,000
Q1 2019 May 10, 2019	BUY	$10.04 - $13.92 $632 - $876	63 New	63 $1,000
Q3 2018 Nov 02, 2018	SELL	$11.6 - $16.54 $222,360 - $317,055	-19,169 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$13.76 - $17.12 $263,765 - $328,173	19,169 New	19,169 $288,000

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$276 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$269 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$233 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$230 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$222 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account